Finoriq research workspace
XBiotech Inc. (XBIT) Institutional Holdings & 13F Ownership
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal. Review XBIT institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
- Company
- XBiotech Inc. (XBIT)
- Ticker
- XBIT
- Market Cap
- $68.6M
- Latest Price
- $2.2501
- Industry
- Biotech & Pharma
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.